Travere Therapeutics, Inc. (TVTX)

59.44 -1.18 (-1.95%) USD  |  NASDAQ  |  Sep 25, 16:00
59.44 0.00 (0.00%) After-Hours: 19:59
More

Travere Therapeutics Cash and Short Term Investments (Annual) : 322.80M for Dec. 31, 2025

Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for TVTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Cash and Short Term Investments (Annual) Data

View and export this data back to 2008. Start Trial.
Date Value
December 31, 2025 322.80M
December 31, 2024 370.70M
December 31, 2023 566.85M
December 31, 2022 450.24M
December 31, 2021 552.88M
December 31, 2020 361.59M
December 31, 2019 398.52M
December 31, 2018 471.54M
December 31, 2017 300.63M
December 31, 2016 255.87M
Date Value
December 31, 2015 229.60M
December 31, 2014 27.76M
December 31, 2013 6.130M
December 31, 2012 0.0114M
February 29, 2012
February 28, 2011 0.004M
February 28, 2010 0.0046M
February 28, 2009 0.0048M
February 29, 2008 0.00

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
BioMarin Pharmaceutical, Inc. 1.561B
TG Therapeutics, Inc. 141.97M
Krystal Biotech, Inc. 827.79M
RenovoRx, Inc. 7.024M
Pelthos Therapeutics, Inc. 18.02M